# Downregulation of hsa_circTLK1 represses non-small cell lung cancer progression by regulating miR-876-3p/SRSF7 axis

**Authors:** Xinzhe Dong, Hui Tian, Peng Ren, Yanxia Liu, Lin Wang

PMC · DOI: 10.1016/j.heliyon.2024.e31972 · Heliyon · 2024-05-25

## TL;DR

This study shows that reducing circTLK1 in non-small cell lung cancer cells slows cancer growth and immune escape by interacting with miR-876-3p and SRSF7.

## Contribution

The novel contribution is identifying the circTLK1/miR-876-3p/SRSF7 axis as a potential therapeutic target in NSCLC.

## Key findings

- circTLK1 is overexpressed in NSCLC cell lines and promotes cancer progression.
- Knockdown of circTLK1 inhibits tumor growth and immune escape in vivo.
- circTLK1 interacts with miR-876-3p, which targets SRSF7 to regulate cancer progression.

## Abstract

This study clarified the expression of cicrTLK1 in non-small cell lung cancer (NSCLC) and explored its role in cancer growth, metastasis and immune escape, providing a potential molecular target and theoretical basis for NSCLC treatment.

The expression levels of circTLK1, miR-876-3p and SRSF7 were determined by RT-qPCR assay. The localization of circTLK1 in NSCLC cells was determined by FISH assay. EdU and cell plate clone formation assay were applied to explore cell proliferation. Wound healing test and Transwell assay were applied to measure the migration and invasion ability. Cell apoptosis rate was detected by FCM assay. Western blotting assay was adopted to measure the protein expression of SRSF7. Dual-luciferase reporter gene assay was applied to assess the interaction between miR-876-3p and circTLK1, and between miR-876-3p and SRSF7. The ability of cirTLK1 to regulate tumor formation in vivo was examined by tumor transplantation experiments in nude mice.

The relative expression of circTLK1 was increased in NSCLC cell lines. Knockdown of circTLK1 prohibited the proliferation, migration, and invasion, and promoted apoptosis rate, but miR-876-3p inhibitor reversed the effects of circTLK1 knockdown. In addition, silencing of circTLK1 overtly restrained the growth of transplanted tumors in vivo, and inhibited immune escape. In addition, circTLK1 interacted with miR-876-3p, and SRSF7 was concluded to be the target gene of miR-876-3p.

In this study, we researched the inhibitory effect of circTLK1knockdown on NSCLC progression and immune escape, and further elucidated the potential regulatory mechanism of circTLK1/miR876-3p/SRSF7 axis.

## Linked entities

- **Genes:** SRSF7 (serine and arginine rich splicing factor 7) [NCBI Gene 6432]
- **Proteins:** SRSF7 (serine and arginine rich splicing factor 7)
- **Diseases:** non-small cell lung cancer (MONDO:0005233)

## Full-text entities

- **Genes:** Srsf7 (serine and arginine-rich splicing factor 7) [NCBI Gene 225027] {aka 35kDa, 9430065L19Rik, 9G8, NX-96, Sfrs7}
- **Diseases:** metastasis (MESH:D009362), NSCLC (MESH:D002289), cancer (MESH:D009369)
- **Chemicals:** EdU (MESH:C022811)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11167351/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11167351/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC11167351/full.md

---
Source: https://tomesphere.com/paper/PMC11167351